BELLICUM PHARMACEUTICALS INC's ticker is and the CUSIP is 079481404. A total of 23 filers reported holding BELLICUM PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $4,607 | -53.2% | 13,962 | +2.0% | 0.00% | – |
Q4 2022 | $9,852 | -1.5% | 13,683 | +57.8% | 0.00% | – |
Q3 2022 | $10,000 | -16.7% | 8,670 | -13.7% | 0.00% | – |
Q2 2022 | $12,000 | -45.5% | 10,048 | -2.8% | 0.00% | – |
Q1 2022 | $22,000 | +175.0% | 10,335 | +84.0% | 0.00% | – |
Q4 2021 | $8,000 | -50.0% | 5,618 | -0.0% | 0.00% | – |
Q3 2021 | $16,000 | 0.0% | 5,619 | +16.7% | 0.00% | – |
Q2 2021 | $16,000 | +433.3% | 4,816 | +460.0% | 0.00% | – |
Q1 2021 | $3,000 | -72.7% | 860 | -71.9% | 0.00% | – |
Q4 2020 | $11,000 | -45.0% | 3,061 | -1.0% | 0.00% | – |
Q3 2020 | $20,000 | +185.7% | 3,093 | +223.9% | 0.00% | – |
Q2 2020 | $7,000 | -94.0% | 955 | -96.1% | 0.00% | – |
Q1 2020 | $116,000 | – | 24,725 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 159,500 | $563,000 | 0.11% |
Ikarian Capital, LLC | 500,000 | $1,765,000 | 0.08% |
Anson Funds Management LP | 99,103 | $350,000 | 0.07% |
GSA CAPITAL PARTNERS LLP | 66,558 | $235,000 | 0.04% |
AJU IB Investment Co., Ltd. | 25,651 | $91,000 | 0.03% |
BOOTHBAY FUND MANAGEMENT, LLC | 53,041 | $187,000 | 0.01% |
SHUFRO ROSE & CO LLC | 12,941 | $46,000 | 0.00% |
Baker Brothers Advisors | 249,123 | $879,000 | 0.00% |
Tekla Capital Management LLC | 6,000 | $21,000 | 0.00% |
Orion Capital Management LLC | 500 | $2,000 | 0.00% |